Indications and uses
■ Intensive EGF peptide cream formulated with EGF, peptide and collagen vitalizes and firms skin for all-day long.
■ Intensive EGF peptide cream formulated with EGF, peptide and collagen vitalizes and firms skin for all-day long.
■ Can be used daily, AM and PM. Gently massage onto face in circular motions untill absorbed.
NIACINAMIDE 2.0%
ADENOSINE 0.04%
Water(Aqua), Glycerin, Butylene Glycol Dicaprylate/Dicaprate, Dimethicone, 1,2-Hexanediol, Methyl Gluceth-20, Betaine, Vinyl Dimethiconee, Diisostearyl Malate, Hydrogenated Vegetable Oil, Dimethicone/Vinyl Dimethicone Crosspolymer, Tri-C14-15 Alkyl Citrate, Arginine, Sodium Acrylate/Sodium AcryloyldimethylTaurate Copolymer, Tocopheryl Acetate, Carbomer, Isohexadecane, Parfum, Panthenol, Butylene glycol, Glyceryl Acrlate/Acrylic acid copolymer, Polysorbate 80, Ethylhexylglycerin, Sorbitan Oleate, Xanthan GUM, PVM/MA Copolymer, Thymus Vulgaris (Thyme) Extract, Phaseolus Radiatus Meristem Cell Culture Extract, Panax ginseng culture extract, Camellia sinensis Callus Culture extracts, Buddleja Davidii Extract, Myrciaria Dubia Fruit Extract, Euterpe Oleracea Fruit Extract, Hydrolyzed Collagen, Caprylyl Glycol, Sodium Benzoate, Potassium Sorbate, Citric Acid, Punica Granatum Fruit Extract, Panax Ginseng Root Extract, Carthamus Tinctorius (Safflower) Flower Extract, Acanthopanax Senticosus (Eleuthero) Root Extract, Solanum Lycopersicum (Tomato) Fruit Extract, Nelumbo Nucifera Seed Extract, Lonicera Japonica (Honeysuckle) Flower Extract, Lilium Tigrinum Extract, Chrysanthemum Indicum Flower Extract, Tropolone, Copper Tripeptide-1, Oligopeptide-1
Skin Brightening
Anti wrinkle
For external use only.
Avoid contact with eyes.
Keep out of reach of children.
Discontinue use if signs of irritation appear.
Keep out of reach of children
■ Intensive EGF peptide cream formulated with EGF, peptide and collagen vitalizes and firms skin for all-day long.
■ Can be used daily, AM and PM. Gently massage onto face in circular motions untill absorbed.
| Class | Version | Type | Effective |
|---|---|---|---|
| ADENOSINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d676a241-be05-4740-b3ee-1a5f2ed422d2 | Product name | 4 | 20180615 |
| dd8bd48f-20d6-43c7-b471-3ae872868afa | Product name | 3 | 20180125 |
| d41954ff-bc63-4b2c-aba0-9146707659d7 | Product name | 2 | 20151117 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73590-0071-1 | COXIR INTENSIVE EGF PEPTIDE | 50 mL in 1 CONTAINER | CREAM | 50 | 1 | |
| 73590-0071-2 | COXIR INTENSIVE EGF PEPTIDE | 1 in 1 CARTON | CREAM | 1 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 73590-0071 | COXIR INTENSIVE EGF PEPTIDE (NIACINAMIDE, ADENOSINE) CREAM [NOKSIBCHO COSMETIC CO., LTD.] | 1 | Current NDC, Legacy NDC, 2 package rows | 20210715_a2caa508-e74b-40d7-8cde-20280731c2a6.zip |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 73590-0071 | 73590-0071-1, 73590-0071-2 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| NIACINAMIDE | 25X51I8RD4 | ACTIB |
| ADENOSINE | K72T3FS567 | ACTIB |
| Water | 059QF0KO0R | IACT |
| Glycerin | PDC6A3C0OX | IACT |
| Butylene Glycol | 3XUS85K0RA | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| COXIR INTENSIVE EGF PEPTIDE | NIACINAMIDE, ADENOSINE | NOKSIBCHO cosmetic Co., Ltd. | a2caa508-e74b-40d7-8cde-20280731c2a6 | 2021-07-14 | Warnings | 73590-0071-1 73590-0071-2 73590-0071 73590007101 73590007102 6a55c458-0a4e-4dc0-8878-ed0164061d93 a2caa508-e74b-40d7-8cde-20280731c2a6 |
Adverse event summaries are temporarily unavailable. Other product information remains available.